{"brief_title": "Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease", "brief_summary": "The goal of this research study is to evaluate the safety and efficacy of the rivastigmine transdermal patch in patients with probable Alzheimer's Disease.", "condition": "Dementia, Alzheimer Type", "intervention_type": "Drug", "intervention_name": "rivastigmine transdermal patch", "criteria": "Inclusion Criteria: - Diagnosis of dementia of the Alzheimer's type - Males, and females who are surgically sterile or one year postmenopausal - A primary caregiver willing to accept responsibility for supervising the treatment Exclusion Criteria: - Any condition (other than Alzheimer's) that could explain patient's dementia - An advanced, severe or unstable disease that may put the patient at special risk - Current diagnosis of active, uncontrolled seizure disorder or unstable cardiovascular disease", "gender": "All", "minimum_age": "50 Years", "maximum_age": "85 Years", "healthy_volunteers": "No", "id": "NCT00099242.xml"}